# Palmitic Acid Induces Dynamic Time-Dependent Alterations in HDACs, Neuronal Chromatin Acetylation, and Gene Expression

**Authors:** Saúl Santiago Rueda-Díaz, Iker Francisco Soto-Santarriaga, Karla Torres-Arciga, Valeria Melissa García-Cruz, Rodrigo González-Barrios, Manuel Flores-León, Clorinda Arias

PMC · DOI: 10.1007/s11064-025-04469-w · 2025-06-30

## TL;DR

This study shows how palmitic acid, a common fatty acid, affects gene regulation and chromatin acetylation in brain cells.

## Contribution

The study reveals new insights into how palmitic acid alters HDACs and gene expression in neurons.

## Key findings

- Palmitic acid changes HDAC levels in a time-dependent manner in neurons.
- It alters chromatin acetylation and affects BDNF and LINE1 gene expression.
- These effects suggest a link between fatty acid exposure and epigenetic regulation in the brain.

## Abstract

Chronic consumption of high fat diets (HFD) is a risk factor for the development of metabolic diseases such as obesity and diabetes, and it is also associated with cognitive impairment and Alzheimer´s disease. Palmitic acid (PA) is a major component of HFD, and high concentrations of this saturated fatty acid exerts pleiotropic actions in cells. The PA effects have been largely studied in peripheral tissues where is considered a driving force for the development of many metabolic diseases such as obesity, insulin resistance and Type II diabetes. In the brain, particularly in neurons, it is able to increase oxidative metabolism, induce insulin resistance, and alter gene expression. However, little is known about how PA-induced metabolic alterations may affect gene expression mechanisms in neurons. One of the most studied PA-dependent mechanisms is associated with the lipid-induced activation of the transcription factors, PPAR-γ and PGC-α, but fewer studies have analyzed the PA-dependent regulation of epigenetic mechanisms. In this study, we identified PA-linked changes in the class I histone deacetylases (HDACs) content associated with chromatin acetylation and with differential expression of the BDNF-encoding gene and the non-coding retrotransposon, LINE1 in differentiated human neuroblastoma cells.

## Linked entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627]
- **Proteins:** PPARG (peroxisome proliferator activated receptor gamma), pgcA (alpha-phosphoglucomutase)
- **Chemicals:** palmitic acid (PubChem CID 985)
- **Diseases:** obesity (MONDO:0011122), diabetes (MONDO:0005015), Alzheimer´s disease (MONDO:0004975)

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}
- **Diseases:** Alzheimer s disease (MESH:D000544), Type II diabetes (MESH:D003924), metabolic diseases (MESH:D008659), cognitive impairment (MESH:D003072), insulin resistance (MESH:D007333), neuroblastoma (MESH:D009447), obesity (MESH:D009765), diabetes (MESH:D003920)
- **Chemicals:** PA (MESH:D019308), saturated fatty acid (MESH:D005227), fat (MESH:D005223), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12208982/full.md

---
Source: https://tomesphere.com/paper/PMC12208982